Clinical Trial Update: Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

View source ↗

Summary

A retrospective registry of patients with acute heparin-induced thrombocytopenia type II (HIT II) was completed, with results posted in 2011; sponsor GlaxoSmith…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heparin-induced Thrombocytopenia

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acute HIT II (Heparin-induced Thrombocytopenia Type II) | Status: COMPLETED | Results posted: 2011-02-25